The business intelligence report titled ‘India COVID-19 Vaccines Market - Growth, Demand, Trends, Opportunity, Forecasts (2021 - 2027)’, available with MarketStudyReport states that India Covid-19 vaccines market is projected record a whopping CAGR of 25% during 2021-2027, thereby amassing a valuation of USD 2.3 Bn by the end of forecast period.
 

According to the findings of the report, growth of India Covid-19 vaccines market is driven by introduction of new vaccines, government aid in vaccine development, and a rise in the number of immunization programs.
 

Request sample copy of this report: https://www.marketstudyreport.com/request-a-sample/3244597/
 

Apart from drivers and opportunities, the research literature also offers a comprehensive outlook on the hurdles that may arise during the study course. It further elaborated on the latest trends, functioning of the businesses in the current scenario, number of doses that have been administered, and forecasts for the growth rate and volume of the market in India.
 

This business sphere is studied extensively on the basis of prominent vaccines that are existing in the Indian market, the role of different ministries with respect to vaccine administration, and the introduction of the digital platform of Co-WIN that is utilized to track the vaccination drive within the country.
 

Moreover, other important aspects such as major collaboration and partnership deals, efforts taken towards R&D and exclusive licensing agreements are investigated and assessed in detail in the report.
 

Speaking of the competitive framework, the report provides an in-depth analysis of the key as well as emerging players in India Covid-19 vaccines market on the parameters of their product portfolio and expansion strategies. The major contenders include Serum Institute of India Pvt. Ltd., and Bharat Biotech International Limited. The emerging players in terms of promising vaccines in clinical development are Gennova Biopharmaceuticals Ltd., Cadila Healthcare Limited (Zydus Cadila), Dr. Reddy’s Laboratories Limited, and Biological E. Limited.